WHO Drug Information - Volume 38, No. 4

14 February 2025
 | Publication
WHO Drug Information - Volume 38, No. 4
Download (7.9 MB)

Overview

The fourth and last issue of volume 38 includes:


Regulatory News: 
  • "19th International Conference of Drug Regulatory Authorities (ICDRA) proceedings and recommendations" 
Pharmaceutical News: 
  • "Establishment of the Specific Absorbance Values for Albendazole and Atazanavir Sulfate and the Application thereof in the QC Testing of Medicines"
  • "World Health Organization External Quality Assurance Scheme - Phase 11"
  • "Quality of Immediate Release Solid Oral Hydrochlorothiazide Tablets in South Africa"
  • "BCS-Based Biowaiver Monograph for Hydrochlorothiazide" 
  • "Potency Testing of Whole-Cell Pertussis-Containing Vaccines: Results of Multilaboratory Assessment of the Pertussis Serological Potency Test".
The second part of the issue, contains the "ATC/DDD Classification (Temporary and Final) List" and concludes with the "Proposed International Nonproprietary Names (INN) List No. 132".
    WHO Team
    Access to Medicines and Health Products (MHP), INN and Classification of Medical Products (INN), Prequalification (PQT), Regulation and Prequalification (RPQ), Regulation and safety (REG)
    Editors
    World Health Organization
    Number of pages
    460
    Reference numbers
    ISBN: 978-92-4-010703-8
    Copyright